Data / Form D filings / Maximum Fidelity Surgical Simulations, Inc.
Maximum Fidelity Surgical Simulations, Inc.: Form D filing
Maximum Fidelity Surgical Simulations, Inc., a biotechnology company in St. Louis, MO, filed a Form D with the SEC in 2024. The latest, on September 18, 2024, reports $2.2 million sold of a $2.2 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4340 DUNCAN AVE., St. Louis, MO, 63110
- Phone
- (573) 447-8694
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2037945
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2024 | New notice | $2,249,998 | $2,249,998 | 9 | Jun 17, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Kinman | Director | |
| Robert Mills | Executive Officer, Director | |
| Richard Clark | Director | |
| David Smoller | Director | |
| Joss Fernandez | Executive Officer, Director |
Every Form D from the week of Sep 16, 2024 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Maximum Fidelity Surgical Simulations, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.